Cite
HARVARD Citation
de Jong, E. et al. (n.d.). Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet infectious diseases. 16 (7), pp. 819-827. [Online].